Thiogenesis Therapeutics Corp's market cap is currently C$36.29M. The company's EPS TTM is C$-0.04; its P/E ratio is ―; Thiogenesis Therapeutics Corp is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Dec 22
Feb 22
Feb 21
Dec 20
Currency in USD
Thiogenesis Therapeutics Corp Earnings and Revenue History
